English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1947]
News [3614]
Articles [95]
Editorials [5]
Conferences [157]
elearning [19]
ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer
ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer
ASCO 2014: Adjuvant ipilimumab improves recurrence-free survival in high-risk melanoma
ASCO 2014: Adjuvant ipilimumab improves recurrence-free survival in high-risk melanoma
ASCO 2014: Ibrutinib significantly delays disease progression and extends survival in resistant or relapsed CLL
ASCO 2014: Ibrutinib significantly delays disease progression and extends survival in resistant or relapsed CLL
Two small UK charities pioneer a big partnership to help children with cancer
Two small UK charities pioneer a big partnership to help children with cancer
Potential new therapeutic approach identified for two types of pancreatic cancer
Potential new therapeutic approach identified for two types of pancreatic cancer
Blocking one protein may lead to new treatments for two types of pancreatic cancer
Blocking one protein may lead to new treatments for two types of pancreatic cancer
Radioimmunotherapy and gemcitabine combination shows early promise for metastatic pancreatic ductal cancer
Radioimmunotherapy and gemcitabine combination shows early promise for metastatic pancreatic ductal cancer
Scientists discover 'brakes' to stop cancer-causing 'car-crashes' in cells
Scientists discover 'brakes' to stop cancer-causing 'car-crashes' in cells
Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer link
Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer...
New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer
New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer
<1...336337338339340...362>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top